What is ACOG stock price today?

ACOG (Alpha Cognition Inc) stock is trading at $5.87 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACOG stock going up or down today?

ACOG stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACOG stock now?

The decision to buy ACOG depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACOG a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACOG based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACOG stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACOG is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACOG's P/E ratio?

P/E ratio data for ACOG will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACOG's market cap?

ACOG (Alpha Cognition Inc) has a market capitalization of $0.12 billion, making it a small-cap stock.

What is ACOG's price to book ratio?

ACOG trades at a price-to-book (P/B) ratio of 3.67, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACOG pay dividends?

ACOG does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACOG's dividend yield?

ACOG does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACOG stock a good long-term investment?

ACOG's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACOG's revenue growth rate?

Revenue growth data for ACOG is available on our dashboard with detailed financial statement analysis.

ACOG is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in ACOG?

Key risks for ACOG include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACOG compare to its competitors?

Compare ACOG to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACOG's performance and positioning.

What is ACOG's stock price target for 2026?

Our AI model provides price targets for ACOG based on fundamental analysis: Bull case $7.63 (+30%), Base case $6.75 (+15%), Bear case $5.28 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACOG?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACOG. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACOG's next earnings report?

ACOG reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACOG - Alpha Cognition Inc

NYSE * Health Care * Pharmaceuticals

$5.87

+$0.15 (+2.62%)

About Alpha Cognition Inc

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.

ACOG Key Statistics

Market Cap

$124.36M

P/B Ratio

3.67

EPS

$-1.38

Profit Margin

-2.6%

Employees

How ACOG Compares to Peers

ACOG is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACOG(This stock)	$124.36M	N/A	0%	-2.6%	-
AAPLApple Inc	$3.66T	33.8	6%	0.3%	vs AAPL
MSFTMicrosoft Corp	$3.38T	36.3	15%	0.4%	vs MSFT
GOOGLAlphabet Inc	$3.89T	32.6	0%	0.3%	vs GOOGL
AMZNAmazon Com	$2.56T	33.8	0%	0.1%	vs AMZN
NVDANvidia Corp	$4.33T	47.9	114%	0.5%	vs NVDA

Alpha Cognition Inc Company Information

Headquarters: British Columbia; Canada
Website: www.alphacognition.com
Sector: Health Care
Industry: Pharmaceuticals

ACOG - Alpha Cognition Inc

About Alpha Cognition Inc

ACOG Key Statistics

How ACOG Compares to Peers

Alpha Cognition Inc Company Information

ACOG Lician Score

ACOG Financial Snowflake

Upcoming Events for ACOG